{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:09:11Z","timestamp":1791425351031,"version":"4.3.3"},"reference-count":53,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The well-established association between TP53 mutations and adverse clinical outcome in a range of human cancers reflects the importance of p53 protein in regulating tumor-cell growth and survival. Although it is theoretically possible for p53 dysfunction to arise through mechanisms that do not involve TP53 mutation, such a phenomenon has not previously been demonstrated in a sporadic tumor. Here, we show that p53 dysfunction in B-cell chronic lymphocytic leukemia (CLL) can occur in the absence of TP53 mutation and that such dysfunction is associated with mutation of the gene encoding ATM, a kinase implicated in p53 activation. Forty-three patients with CLL were examined for p53 dysfunction, as detected by impaired up-regulation of p53 and of the p53-dependent protein p21CIP1\/WAF1 after exposure to ionizing radiation (IR). Thirty (70%) patients had normal p53 responses and underwent progressive IR-induced apoptosis. In 13 (30%) patients, p21 up-regulation was markedly impaired, indicating p53 dysfunction. Six (14%) of these patients with p53 dysfunction had increased baseline levels of p53, were found to have TP53 mutations, and were completely resistant to IR-induced apoptosis. In the other 7 (16%) patients with p53 dysfunction, IR-induced p53 up-regulation and apoptosis were markedly impaired, but baseline levels of p53 were not increased, and no TP53 mutations were detected. Each of these patients was found to have at least one ATM mutation, and a variable reduction in ATM protein was detected in all 4 patients examined. This is the first study to provide a direct demonstration that p53 dysfunction can arise in a sporadic tumor by a mechanism that does not involve TP53 mutation.<\/jats:p>","DOI":"10.1182\/blood.v98.3.814","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T08:46:47Z","timestamp":1027759607000},"page":"814-822","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":192,"title":["p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative toTP53 mutation"],"prefix":"10.1182","volume":"98","author":[{"given":"Andrew R.","family":"Pettitt","sequence":"first","affiliation":[{"name":"From the Department of Haematology, University of Liverpool, and the CRC Institute for Cancer Studies, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Sherrington","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, University of Liverpool, and the CRC Institute for Cancer Studies, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Stewart","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, University of Liverpool, and the CRC Institute for Cancer Studies, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cawley","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, University of Liverpool, and the CRC Institute for Cancer Studies, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Malcolm R.","family":"Taylor","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, University of Liverpool, and the CRC Institute for Cancer Studies, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Stankovic","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, University of Liverpool, and the CRC Institute for Cancer Studies, University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021221491802800_B1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic lymphocytic leukemia.","volume":"333","author":"Rozman","year":"1995","journal-title":"N Engl J Med."},{"key":"2020021221491802800_B2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","article-title":"B-cell chronic lymphocytic leukemia: a bird of a different feather.","volume":"17","author":"Caligaris-Capio","year":"1999","journal-title":"J Clin Oncol."},{"key":"2020021221491802800_B3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1365-2141.1997.4723278.x","article-title":"p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis.","volume":"99","author":"Lens","year":"1997","journal-title":"Br J Haematol."},{"key":"2020021221491802800_B4","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood.V82.11.3452.3452","article-title":"p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1\/MDR3 gene expression.","volume":"82","author":"El Rouby","year":"1993","journal-title":"Blood."},{"key":"2020021221491802800_B5","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies.","volume":"84","author":"Wattel","year":"1994","journal-title":"Blood."},{"key":"2020021221491802800_B6","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580","article-title":"p53 gene deletion predicts for poor survival and non-response to therapy with purine analogues in chronic B-cell leukaemias.","volume":"85","author":"Dohner","year":"1995","journal-title":"Blood."},{"key":"2020021221491802800_B7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"p53, guardian of the genome.","volume":"358","author":"Lane","year":"1992","journal-title":"Nature."},{"key":"2020021221491802800_B8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gad.10.9.1054","article-title":"p53: puzzle and paradigm.","volume":"10","author":"Ko","year":"1996","journal-title":"Genes Dev."},{"key":"2020021221491802800_B9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53, the cellular gatekeeper for growth and division.","volume":"88","author":"Levine","year":"1997","journal-title":"Cell."},{"key":"2020021221491802800_B10","first-page":"6301","article-title":"Participation of p53 protein in the cellular response to DNA damage.","volume":"51","author":"Kastan","year":"1991","journal-title":"Cancer Res."},{"key":"2020021221491802800_B11","first-page":"307","article-title":"Induction of nuclear accumulation of the tumour suppressor protein p53 by DNA-damaging agents.","volume":"8","author":"Fritsche","year":"1993","journal-title":"Oncogene."},{"key":"2020021221491802800_B12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumour suppression.","volume":"75","author":"El-Deiry","year":"1993","journal-title":"Cell."},{"key":"2020021221491802800_B13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumour suppressor p53 is a direct transcriptional activator of the human bax gene.","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell."},{"key":"2020021221491802800_B14","first-page":"3131","article-title":"Identification of a p53-dependent negative response element in the bcl-2 gene.","volume":"54","author":"Miyashita","year":"1994","journal-title":"Cancer Res."},{"key":"2020021221491802800_B15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/oxfordjournals.bmb.a072911","article-title":"p53 and human cancers.","volume":"50","author":"Lane","year":"1994","journal-title":"Br Med Bull."},{"key":"2020021221491802800_B16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0092-8674(94)90519-3","article-title":"How loops, \u03b2 sheets, and \u03b1 helices help us to understand p53.","volume":"78","author":"Prives","year":"1994","journal-title":"Cell."},{"key":"2020021221491802800_B17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10428199509056825","article-title":"p53 gene mutations in lymphoid disease and their possible relevance to drug resistance.","volume":"17","author":"Newcombe","year":"1995","journal-title":"Leuk Lymphoma."},{"key":"2020021221491802800_B18","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood.V79.7.1796.1796","article-title":"Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method.","volume":"79","author":"Anastasi","year":"1992","journal-title":"Blood."},{"key":"2020021221491802800_B19","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V89.7.2516","article-title":"11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis.","volume":"89","author":"Dohner","year":"1997","journal-title":"Blood."},{"key":"2020021221491802800_B20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/358080a0","article-title":"Amplification of a gene encoding a p53-associated protein in human sarcomas.","volume":"358","author":"Oliner","year":"1992","journal-title":"Nature."},{"key":"2020021221491802800_B21","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V84.9.3158.3158","article-title":"The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.","volume":"84","author":"Watanabe","year":"1994","journal-title":"Blood."},{"key":"2020021221491802800_B22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/10428199509051698","article-title":"Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosis.","volume":"17","author":"Bues-Ramos","year":"1995","journal-title":"Leuk Lymphoma."},{"key":"2020021221491802800_B23","first-page":"546","article-title":"B-cell chronic lymphocytic leukemia: association between the MDM2 and p53 protein expression and trisomy 12 [abstract].","volume":"94","author":"Hjalmar","year":"1999","journal-title":"Blood."},{"key":"2020021221491802800_B24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0092-8674(00)81774-2","article-title":"Signaling to p53: breaking the MDM2\u2013p53 circuit.","volume":"95","author":"Prives","year":"1998","journal-title":"Cell."},{"key":"2020021221491802800_B25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/095530098142185","article-title":"What has the cloning of the ATM gene told us about ataxia telangiectasia?","volume":"73","author":"Taylor","year":"1998","journal-title":"Int J Radiol Biol."},{"key":"2020021221491802800_B26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/3882","article-title":"ATM associates with and phosphorylates p53: mapping the region of interaction.","volume":"20","author":"Khanna","year":"1998","journal-title":"Nat Genet."},{"key":"2020021221491802800_B27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/542","article-title":"ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins.","volume":"19","author":"Waterman","year":"1998","journal-title":"Nat Genet."},{"key":"2020021221491802800_B28","first-page":"4552","article-title":"Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.","volume":"58","author":"Starostik","year":"1998","journal-title":"Cancer Res."},{"key":"2020021221491802800_B29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(98)10117-4","article-title":"Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.","volume":"353","author":"Stankovic","year":"1999","journal-title":"Lancet."},{"key":"2020021221491802800_B30","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V94.2.748","article-title":"Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.","volume":"94","author":"Schaffner","year":"1999","journal-title":"Blood."},{"key":"2020021221491802800_B31","first-page":"24","article-title":"ATM mutations in B-cell chronic lymphocytic leukemia.","volume":"59","author":"Bullrich","year":"1999","journal-title":"Cancer Res."},{"key":"2020021221491802800_B32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1297-453","article-title":"Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways.","volume":"17","author":"Barlow","year":"1997","journal-title":"Nat Genet."},{"key":"2020021221491802800_B33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ng0897-397","article-title":"Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity.","volume":"16","author":"Westphal","year":"1997","journal-title":"Nat Genet."},{"key":"2020021221491802800_B34","first-page":"3307","article-title":"Ionising radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells.","volume":"8","author":"Khanna","year":"1993","journal-title":"Oncogene."},{"key":"2020021221491802800_B35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3","article-title":"The p53 pathway.","volume":"187","author":"Prives","year":"1999","journal-title":"J Pathol."},{"key":"2020021221491802800_B36","first-page":"1943","article-title":"Coupling between gamma irradiation, p53 induction and the apoptotic response depends on cell type in vivo.","volume":"108","author":"Midgeley","year":"1995","journal-title":"J Cell Sci."},{"key":"2020021221491802800_B37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/273345a0","article-title":"Role of cell shape in growth control.","volume":"273","author":"Folkman","year":"1978","journal-title":"Nature."},{"key":"2020021221491802800_B38","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1128\/MCB.13.7.4242","article-title":"Induction of cellular p53 activity by DNA-damaging agents and growth arrest.","volume":"13","author":"Zhan","year":"1993","journal-title":"Mol Cell Biol."},{"key":"2020021221491802800_B39","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1093\/nar\/19.14.4008","article-title":"\u201cTouchdown\u201d PCR to circumvent spurious priming during gene amplification [abstract].","volume":"19","author":"Don","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"2020021221491802800_B40","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.4049\/jimmunol.164.7.3887","article-title":"Granulocyte-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes.","volume":"164","author":"Harris","year":"2000","journal-title":"J Immunol."},{"key":"2020021221491802800_B41","first-page":"470","article-title":"Restriction endonuclease fingerprinting (REF): a sensitive method for screening in long contiguous segments of DNA.","volume":"18","author":"Liu","year":"1995","journal-title":"Biol Tech."},{"key":"2020021221491802800_B42","first-page":"2726","article-title":"The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation.","volume":"56","author":"Vorechovsky","year":"1996","journal-title":"Cancer Res."},{"key":"2020021221491802800_B43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2401061","article-title":"The study of apoptotic cells by flow cytometry.","volume":"12","author":"Ormerod","year":"1998","journal-title":"Leukemia."},{"key":"2020021221491802800_B44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-4827(92)90393-M","article-title":"Induction of apoptosis in chronic lymphocytic leukemia cells and its prevenetion by phorbol ester.","volume":"198","author":"Forbes","year":"1992","journal-title":"Exp Cell Res."},{"key":"2020021221491802800_B45","first-page":"78","article-title":"Hormone-induced cell death: purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment.","volume":"109","author":"Wyllie","year":"1982","journal-title":"Am J Pathol."},{"key":"2020021221491802800_B46","first-page":"3976","article-title":"Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.","volume":"53","author":"Kaufmann","year":"1993","journal-title":"Cancer Res."},{"key":"2020021221491802800_B47","first-page":"11","article-title":"Molecular biology of chronic lymphocytic leukaemia.","volume":"25","author":"Reed","year":"1998","journal-title":"Semin Oncol."},{"key":"2020021221491802800_B48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","article-title":"p53 is required for radiation-induced apoptosis in mouse thymocytes.","volume":"362","author":"Lowe","year":"1993","journal-title":"Nature."},{"key":"2020021221491802800_B49","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","article-title":"Thymocyte apoptosis induced by p53-dependent and independent pathways.","volume":"362","author":"Clarke","year":"1993","journal-title":"Nature."},{"key":"2020021221491802800_B50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0092-8674(92)90421-8","article-title":"p53 function and dysfunction.","volume":"70","author":"Vogelstein","year":"1992","journal-title":"Cell."},{"key":"2020021221491802800_B51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/35044005","article-title":"The DNA damage response: putting checkpoints in prospective.","volume":"408","author":"Zhou","year":"2000","journal-title":"Nature."},{"key":"2020021221491802800_B52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","article-title":"p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.","volume":"74","author":"Lowe","year":"1993","journal-title":"Cell."},{"key":"2020021221491802800_B53","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0092-8674(91)90384-B","article-title":"Cotranslation of activated mutant p53 with wild-type drives the wild-type p53 protein into the mutant conformation.","volume":"65","author":"Milner","year":"1991","journal-title":"Cell."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/3\/814\/1676114\/h8150100814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/3\/814\/1676114\/h8150100814.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T21:57:10Z","timestamp":1581544630000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/98\/3\/814\/53305\/p53-dysfunction-in-Bcell-chronic-lymphocytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,1]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,8,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v98.3.814","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8,1]]}}}